China Shineway Pharmaceutical Group Limited

DB:C1S Stock Report

Market Cap: €804.9m

China Shineway Pharmaceutical Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure4.1yrs

Recent management updates

Recent updates

CEO

China Shineway Pharmaceutical Group has no CEO, or we have no data on them.

Board Members

NamePositionTenureCompensationOwnership
Zhenjiang Li
Co-Founder & Executive Chairman22.1yrsCN¥25.64m72.39%
€ 582.6m
Yunxia Xin
Co-Founder & Executive Director20.3yrsCN¥13.20m0.071%
€ 575.4k
Huimin Li
Executive Director20.3yrsCN¥2.12m0.14%
€ 1.1m
Shun Fai Liu
Independent Non-Executive Director3yrsCN¥142.00kno data
Guihua Wang
Independent Non-Executive Director1.6yrsCN¥106.00kno data
Wencheng Zhou
Non-Executive Director4.1yrsCN¥142.00kno data
Yat On Yew
Independent Non-Executive Director2.1yrsCN¥142.00kno data

4.1yrs

Average Tenure

56yo

Average Age

Experienced Board: C1S's board of directors are considered experienced (4.1 years average tenure).